California Medical Board Attorney Fee Petition Mechanics: Tyler Odyssey Civil Complaint Date as Primary Welch Anchor, CMB BreEZe License Verification Database as Secondary Institutional Anchor (the Only CMB BreEZe Module Anchor in This Series, Covering MD/DO Licensees by License Number, Issue Date, Expiration Date, and Clear/Probation/Suspended/Revoked Status), CLRA § 1780 Mandatory Attorney Fees and Bus. & Prof. Code § 2052(b) Treble Damages for Patients Harmed by Unlicensed Medical Practice Including Patients Who Received Controlled Substance Prescriptions from Practitioners Lacking DEA Certificate of Registration Authority and Patients Who Underwent Unlicensed Surgical Procedures

Statutory Framework: Bus. & Prof. Code § 2052 and the California Medical Practice Act — CMB License Requirements, Prohibited Conduct, § 2052(b) Treble Damages, and CLRA § 1780 Mandatory Attorney Fees for Unlicensed Medical Practice

California Business and Professions Code § 2052 is the operative licensure prohibition of the California Medical Practice Act, establishing that no person may practice medicine, surgery, or any system or mode of treating the sick or afflicted in California — or diagnose, treat, correct, advise, or prescribe for any physical or mental ailment of another person — or represent themselves in any manner as a physician and surgeon, without a current license issued by the Medical Board of California. The CMB administers California's physician and surgeon licensing program under the oversight of the Department of Consumer Affairs and in coordination with the California Medical Quality Hearing Panel, which conducts disciplinary hearings resulting in CMB Accusations under Bus. & Prof. Code § 2227. The CMB issues licenses to both Medical Doctors (MDs, allopathic physicians who have completed accredited allopathic medical school programs and passed all three Steps of the United States Medical Licensing Examination administered by the Federation of State Medical Boards and the National Board of Medical Examiners) and Doctors of Osteopathic Medicine (DOs, osteopathic physicians who have completed accredited osteopathic medical school programs and passed COMLEX-USA Levels 1, 2, and 3 administered by the National Board of Osteopathic Medical Examiners) — covering all clinical specialties from family medicine and internal medicine through general surgery, orthopedic surgery, obstetrics and gynecology, psychiatry, oncology, cardiology, neurology, radiology, anesthesiology, and every other specialty and subspecialty recognized by the American Board of Medical Specialties and the American Osteopathic Association Bureau of Osteopathic Specialists. Section 2052 makes unlicensed practice of medicine a public offense — a felony under Bus. & Prof. Code § 2053 when the unlicensed practice causes death or serious bodily injury — and creates the civil liability foundation for CLRA § 1780 consumer fraud claims and § 2052(b) treble damages civil actions.

Bus. & Prof. Code § 2052(b) is the civil remedy provision specific to unlicensed medical practice: it provides that any person who has suffered damages as a result of a violation of § 2052 — including any patient who received medical services, surgical procedures, or controlled substance prescriptions from an unlicensed practitioner — has a cause of action against the unlicensed practitioner for three times the amount of actual damages suffered. The § 2052(b) treble damages civil cause of action is a distinct statutory remedy from the CLRA § 1780 mandatory attorney fee claim: § 2052(b) creates a statutory damages multiplier (actual damages trebled) applicable to the full range of economic and non-economic patient harms arising from the unlicensed practice, while CLRA § 1780 creates a separate mandatory fee-shifting mechanism for the attorney fees incurred in pursuing the unlicensed practice claim. Both remedies are available simultaneously in the same civil action, allowing the prevailing patient plaintiff to recover trebled actual damages under § 2052(b) plus mandatory attorney fees under CLRA § 1780, with the § 2052(b) treble damages briefing constituting a distinct component of the attorney fee petition lodestar under the Missouri v. Jenkins (491 U.S. 274 (1989)) fees-on-fees doctrine. The scope of § 2052 violations triggering these remedies encompasses multiple distinct patterns of unlicensed medical practice: individuals with no CMB licensure — foreign medical graduates, expelled medical students, lapsed licensees, imposters using fabricated credentials — practicing medicine, prescribing controlled substances, or performing procedures while representing themselves as licensed California physicians; former CMB licensees whose licenses have expired, been suspended, or been revoked continuing to practice; and practitioners holding valid licenses in other medical disciplines (e.g., nurse practitioners, physician assistants, chiropractors, naturopathic doctors) who practice beyond their licensed scope in ways that constitute physician-level medical practice requiring a CMB MD or DO license.

The CLRA civil remedy arises because medical services purchased by patients satisfy the definition of "consumer services" under Civil Code § 1761(b). Every practitioner who represents themselves as an MD or DO — using a physician credential designation, operating a "medical office" or "clinic," prescribing medications on prescription pads bearing a physician's name, or providing services on platforms advertising physician-level medical care — impliedly represents current CMB licensure, a representation that constitutes a misrepresentation of service provider qualifications under Civil Code § 1770(a)(14) when the practitioner lacks current CMB licensure. Section 1780(e) mandates that "the court shall award court costs and attorney's fees to a prevailing plaintiff in litigation filed pursuant to this section" — the mandatory "shall award" language eliminates all judicial discretion over the attorney fee award. UCL § 17200 provides a parallel per se unlawful business practice theory supporting restitution of all fees paid to the unlicensed practitioner and injunctive relief against continued credential misrepresentation and unlicensed practice. CCP § 1021.5 independently supports private attorney general fee enhancement in cases where the unlicensed practitioner treated a significant volume of patients, demonstrating broad public harm from the unlicensed practice.

Three Unique Distinctions in the Fee-Petition-Mechanics Series

• THE ONLY CMB (Medical Board of California) BreEZe License Verification Database anchor in the entire fee-petition-mechanics series — covering MD/DO licensees by license number, issue date, expiration date, and Clear/Probation/Suspended/Revoked status — entirely distinct from the PAB BreEZe module (physician assistant licenses), the BRN BreEZe module (registered nursing licenses), the BVNPT database (vocational nursing and psychiatric technician licenses), the Dental Board BreEZe, the Psychology Board BreEZe, and all other DCA board databases in the series: the Medical Board of California BreEZe License Verification Database is the only secondary anchor in the series tied to the CMB's physician and surgeon licensing program — a unified database covering both MD (allopathic, Medical Doctor) and DO (osteopathic, Doctor of Osteopathic Medicine) licensees under a single CMB BreEZe module; MD licenses are issued in an A-NNNNN format (e.g., A-12345, where the "A" prefix identifies a CMB-issued Physician and Surgeon license and the numeric component is a sequential identifier assigned upon initial licensure), while DO licenses issued by CMB follow a similar but distinct numeric format reflecting the osteopathic pathway; both license types appear in the same CMB BreEZe module and are retrievable through the same online search interface by the licensee's name or license number; the CMB BreEZe records: the licensee's full legal name (the name under which the CMB license was issued), the license number and license type (Physician and Surgeon — covering both MD and DO regardless of the degree designation), the initial license issue date, the current expiration date (biennial renewal deadline; CMB licenses must be renewed every two years to remain in Clear status), and the current status: Clear (the CMB licensee holds a valid, current license in good standing with no active disciplinary conditions — authorized to practice medicine in California), Probation (the licensee is subject to CMB probationary terms imposed following a formal disciplinary proceeding — a Probation status may restrict the licensee's practice to specific settings, require practice monitors, mandate drug testing, restrict controlled substance prescribing authority, or impose other conditions; a Probation-status licensee is technically licensed to practice medicine but subject to CMB probationary conditions that may be relevant to the patient's harm analysis), Suspended (the CMB has issued a disciplinary order suspending the licensee's practice rights — a suspended CMB licensee has no authority to practice medicine in California during the suspension period, making any medical services provided during the suspension period equivalent to unlicensed practice for § 2052 civil liability purposes), or Revoked (the CMB has permanently revoked the licensee's physician and surgeon certificate — a revoked CMB licensee has permanently lost their California medical license and any medical services performed after revocation constitute unlicensed practice under § 2052 regardless of the practitioner's educational credentials or prior licensure history); the CMB BreEZe module is entirely distinct from: the PAB BreEZe module, which covers Physician Assistant licenses issued by the Physician Assistant Board — a separate DCA board whose licensees may prescribe controlled substances and perform medical procedures only under a current CMB-licensed supervising physician's collaborative practice agreement, meaning that the CMB MD or DO license is the foundational predicate for all physician-supervised Physician Assistant practice — a PA lacks both the CMB license and the collaborative agreement authority if the supervising physician's CMB license is invalid; the BRN BreEZe module, which covers Registered Nursing licenses and does not include physician-level diagnosis, prescribing, or surgical authority; the BVNPT database, which covers Licensed Vocational Nurses and Psychiatric Technicians under a separate non-DCA board; the Dental Board BreEZe, which covers dentists and dental specialists; the Psychology Board BreEZe, which covers licensed psychologists; and all other DCA board databases in the series covering non-physician healthcare practitioners; the individual-only licensing architecture of the CMB BreEZe — CMB licenses only individual MDs and DOs, not medical corporations, medical groups, or physician practice entities (medical corporations must register separately under Corporations Code § 13401 with their controlling physician's CMB license number listed, but the medical corporation registration is separate from the CMB BreEZe module, which contains only individual physician license records) — means that the CMB BreEZe secondary anchor search is a targeted individual-license search by the defendant practitioner's name and license number, distinct from databases covering both individual and entity licenses.
• THE ONLY page where unlicensed practice simultaneously violates California Bus. & Prof. Code § 2052 AND creates federal controlled substance distribution criminal exposure under 21 U.S.C. § 841(a)(1): every controlled substance prescription issued without both (a) a current California Medical Board MD or DO license, AND (b) a valid DEA Certificate of Registration (COR) naming the prescriber as an authorized DEA registrant in the applicable COR schedule, is simultaneously a § 2052 unlicensed medical practice violation AND a 21 U.S.C. § 841(a)(1) federal controlled substance distribution offense; Schedule II controlled substances include opioid analgesics such as oxycodone (OxyContin, Percocet), hydrocodone (Vicodin, Norco), fentanyl (Duragesic), oxymorphone, hydromorphone (Dilaudid), and methadone, as well as stimulants such as amphetamine (Adderall), dextroamphetamine (Dexedrine), and methylphenidate (Ritalin, Concerta); Schedule III–IV controlled substances include benzodiazepines such as alprazolam (Xanax), diazepam (Valium), lorazepam (Ativan), and clonazepam (Klonopin), as well as buprenorphine (Suboxone, for opioid use disorder treatment), carisoprodol (Soma), and pregabalin (Lyrica); gabapentin (Neurontin) is classified as a Schedule V controlled substance under California Health and Safety Code § 11056(h) even though it is not currently federally scheduled, meaning California-specific prescribing authority analysis is required for unlicensed practitioners issuing gabapentin prescriptions; an unlicensed practitioner presenting themselves as a prescribing MD or DO lacks both the foundational CMB medical license (the California state prescribing predicate) and the DEA COR naming them as the prescriber (the federal controlled substance prescribing authority), because the DEA issues CORs only to practitioners who hold a current state medical license in the state where they will prescribe — a practitioner who lacks a CMB MD or DO license cannot obtain or maintain a valid California DEA COR for Schedule II–V controlled substances, and a DEA COR obtained through misrepresentation of CMB licensure status is invalid; this simultaneous dual violation — § 2052 state civil/criminal and 21 U.S.C. § 841(a)(1) federal criminal — is distinct from the PAB BreEZe page (Bus. & Prof. Code § 3526), because a Physician Assistant who lacks a current PAB license and lacks a current collaborative practice agreement with a CMB-licensed supervising physician cannot lawfully prescribe any controlled substances; on the PAB page, the unlicensed PA is a practitioner who may have had (or may never have had) PA licensure, but is acting beyond the scope of PA authority by prescribing without a valid collaborative agreement; on the CMB page, the unlicensed practitioner is presenting themselves as the prescribing MD or DO — the foundational physician-level prescriber — lacking both the CMB license and the DEA COR tied to that CMB license; crucially, the Controlled Substances Act (21 U.S.C. § 801 et seq.) creates no private civil right of action for patients harmed by controlled substance prescriptions from unlicensed practitioners: 21 U.S.C. § 841(a)(1) establishes criminal penalties for knowingly or intentionally distributing or dispensing a controlled substance except as authorized by the CSA, but federal courts have uniformly held that § 841 creates no private civil cause of action; patients who received controlled substance prescriptions from an unlicensed practitioner cannot invoke 21 U.S.C. § 841 as a basis for mandatory civil attorney fees; this absence of federal civil fee-shifting for the controlled substance dimension of the unlicensed practice makes the entire CLRA § 1780 lodestar — including all time spent on DEA COR verification, CURES 2.0 prescription history analysis, and controlled substance harm documentation — PURE KETCHUM, eligible for the full Ketchum v. Moses contingency multiplier without any Dague constraint.
• THE ONLY page where the victim class includes patients who underwent unlicensed SURGICAL PROCEDURES — and where Bus. & Prof. Code § 2052(b) specifically provides a treble damages civil cause of action making actual damages trebled a distinct component of the attorney fee petition lodestar briefing: unlicensed practitioners performing physician-level surgical and invasive procedures without CMB licensure cause immediately physically irreversible harms that are categorically distinct from the harms documented on every other page in the fee-petition-mechanics series; specific unlicensed procedures and their associated harm profiles include: suturing and skin closure (improper wound repair technique — dehiscence, infection, hypertrophic scarring, damage to underlying nerves or vessels); excision of cysts, lipomas, moles, lesions, and foreign bodies (improper excision technique — retained foreign body, wound infection, damage to underlying nerves or vessels from blind dissection, inadequate pathology specimen submission for biopsy); incision and drainage of abscesses (inadequate anesthesia, improper wound packing, failure to recognize necrotizing fasciitis requiring emergent surgical debridement, bacteremia and sepsis from inadequate drainage); joint injections of corticosteroid, hyaluronic acid, or platelet-rich plasma (septic joint from non-sterile technique — a surgical emergency requiring emergent joint aspiration and intravenous antibiotics; permanent joint destruction from repeated corticosteroid injection by an unlicensed practitioner without imaging guidance or proper patient selection); nerve blocks (inadvertent intraneural injection causing permanent neuropathy; inadvertent intravascular injection causing systemic local anesthetic toxicity — cardiovascular collapse and seizure); lumbar punctures and spinal taps (post-dural puncture headache, subarachnoid hemorrhage from traumatic tap, spinal epidural hematoma or abscess from non-sterile technique); procedural sedation and anesthesia administration (anesthesia overdose — respiratory depression, aspiration, anoxic brain injury, or death; anaphylaxis from unlicensed administration of propofol, ketamine, or midazolam without CMB-licensed anesthesia oversight and resuscitation capability); and other invasive procedures performed without CMB licensure — these harm categories are distinct from the Naturopathic Medicine Committee page (Bus. & Prof. Code § 3640.5(e), which expressly authorizes licensed NMC practitioners to perform naturopathic minor surgery including minor office procedures and wound care as part of their licensed NMC scope of practice — the NMC page involves a practitioner exceeding their licensed NMC scope; the CMB page involves a practitioner performing what appears to be physician-level surgical procedures without any California license of any kind) and from the PAB page (Physician Assistants may assist in surgery and perform certain procedures under a collaborative practice agreement with a CMB-licensed supervising physician — an unlicensed PA lacks both the PA license and the collaborative agreement predicate for surgical assisting); Bus. & Prof. Code § 2052(b) specifically provides that a person who has suffered damage as a result of a § 2052 violation may bring a civil action for three times the amount of actual damages suffered — a statutory treble damages multiplier applied to: all amounts paid to the unlicensed practitioner for medical, surgical, and prescription services; all downstream medical costs caused by the unlicensed practice (corrective surgery, hospitalization, specialist consultation, wound care, rehabilitation); and all non-economic damages supported by patient medical evidence; the § 2052(b) treble damages briefing is a distinct component of the CLRA § 1780 fee petition lodestar — the attorney documents separately the legal work performed on the § 2052(b) treble damages count (actual damages quantification, medical expert consultation, § 2052(b) civil cause of action pleading) and seeks Missouri v. Jenkins fees-on-fees for all fee petition preparation time attributable to the § 2052(b) treble damages briefing.

PURE KETCHUM — Bus. & Prof. Code § 2052 unlicensed medical practice claims with no concurrent federal statute providing mandatory civil attorney fee-shifting; no Ketchum/Dague split for the CLRA § 1780 lodestar: no federal statute creates a private right of action with mandatory attorney fees specifically for patients harmed by unlicensed California medical practice. The Controlled Substances Act (21 U.S.C. § 801 et seq.) creates criminal liability for unlicensed controlled substance distribution but no private civil right of action for patients — the United States Supreme Court has recognized that implied private rights of action under criminal statutes require a clear congressional intent to create such rights, which is absent from 21 U.S.C. § 841. 42 U.S.C. § 1983 requires state action under color of state law and does not apply to private unlicensed practitioners who have no connection to governmental authority. The Federal Food, Drug, and Cosmetic Act (21 U.S.C. § 301 et seq.) regulates drug approval and labeling but creates no private right of action for patients harmed by unlicensed prescription of approved or unapproved drugs. The Health Insurance Portability and Accountability Act (HIPAA) creates no private civil right of action for patients, only regulatory enforcement by HHS Office for Civil Rights. For the CLRA § 1780 unlicensed medical practice claim — including the controlled substance prescribing dimension and the surgical procedure dimension — the entire lodestar from the CMB BreEZe search date through the Tyler Odyssey complaint through judgment is pure Ketchum, eligible for the full Ketchum v. Moses (24 Cal.4th 1122 (2001)) contingency multiplier without any Dague v. City of Hamtramck (505 U.S. 557 (1992)) constraint on any portion of the fee award.

Primary Welch Anchor: Tyler Odyssey Civil Complaint Filing Date

The Tyler Odyssey civil complaint filing date is the primary Welch temporal anchor for the CLRA § 1780 attorney fee petition lodestar in Bus. & Prof. Code § 2052 unlicensed medical practice cases. In unlicensed physician practice matters, the Tyler Odyssey complaint is typically filed after the plaintiff attorney has: confirmed through the CMB BreEZe License Verification Database that the defendant practitioner lacks a current MD or DO license, or holds a CMB license in Probation, Suspended, or Revoked status during the period the challenged medical services were rendered; reviewed the defendant's medical records, treatment notes, prescriptions, and procedure reports to document the specific unlicensed medical services performed and the patient harm profile arising from those services; verified through the DEA Diversion Control Division's online registrant search whether the defendant held a valid DEA Certificate of Registration (COR) for controlled substance prescribing authority in California, and cross-referenced the defendant's COR status with the CURES 2.0 prescription history to identify controlled substance prescriptions issued under the defendant's name or a fictitious or borrowed DEA COR number; and performed a preliminary § 2052(b) treble damages analysis quantifying the actual damages arising from the unlicensed practice — including the fees paid to the unlicensed practitioner, the downstream medical costs of treating complications, and the non-economic harm — as a predicate for the treble damages briefing in the Tyler Odyssey complaint.

The pre-complaint advisory period in unlicensed medical practice cases can be initiated through multiple discovery pathways: a patient who receives a prescription from a provider who lacks both CMB licensure and a DEA COR, and who discovers the unlicensed status when the pharmacy queries the DEA registrant database or the CMB BreEZe and refuses to fill the prescription; a patient who underwent a surgical procedure — suturing, excision, joint injection, nerve block, or procedural sedation — performed by an unlicensed practitioner in a "clinic," "wellness center," or "medical spa" setting, and who suffered a complication (wound infection, septic joint, nerve injury, anesthesia adverse event) that a licensed CMB physician's standard of care would have prevented or promptly managed; a patient who received a diagnosis and treatment plan from an unlicensed practitioner, relied on that treatment plan in lieu of seeking care from a licensed physician, and suffered harm from the delayed or incorrect treatment; a patient who received controlled substance prescriptions from an unlicensed practitioner and who suffered harm from the unmonitored controlled substance use (including overdose, dependency, or drug-drug interactions) without the CURES 2.0 prescriber monitoring protocol that a CMB-licensed physician would have applied; or a licensing board complaint filed with the CMB Complaint Unit that triggers a CMB investigation revealing the defendant's unlicensed status and prompting the affected patient or their family to seek civil counsel.

The Tyler Odyssey complaint in unlicensed medical practice cases typically pleads: (1) a CLRA § 1780 claim predicated on Bus. & Prof. Code § 2052 unlicensed practice — a per se misrepresentation of service provider qualifications under Civ. Code § 1770(a)(14) and a misrepresentation of service characteristics under § 1770(a)(5); (2) a Bus. & Prof. Code § 2052(b) civil cause of action for treble damages, pleading actual damages in detail — all fees paid to the unlicensed practitioner, all downstream medical costs of treating complications, and all non-economic damages — and seeking trebling of those damages as a distinct statutory remedy; (3) a UCL § 17200 unlawful business practice claim predicated on the § 2052 violation — supporting injunctive relief against continued credential misrepresentation and unlicensed practice, and restitution of all fees paid to the unlicensed practitioner; (4) a fraud or intentional misrepresentation claim based on the defendant's knowing misrepresentation of CMB licensure, DEA COR status, and medical credentials in the patient engagement; and (5) in cases involving surgical procedure patients, a negligence claim documenting the specific standard of care violations, the causation analysis (supported by CMB-licensed medical expert opinion), and the physical harms proximately caused by the unlicensed procedure, with the negligence damages supporting the § 2052(b) treble damages quantification. The Tyler Odyssey complaint filing date is the primary Welch anchor from which the complete lodestar — from the earliest pre-complaint CMB BreEZe search through the fee petition — is measured and documented.

Secondary Institutional Anchor: CMB BreEZe License Verification Database

The Medical Board of California BreEZe License Verification Database is the secondary institutional anchor in CLRA § 1780 unlicensed medical practice fee petition cases — THE ONLY secondary institutional anchor in the entire fee-petition-mechanics series tied specifically to the CMB's physician and surgeon licensing program. The CMB BreEZe module records each MD and DO licensee's: full legal name (the name under which the CMB license was issued and under which the licensee is authorized to practice medicine); license number and license type (Physician and Surgeon — MD licenses are issued in A-NNNNN format, e.g., A-12345, where the "A" prefix identifies a CMB Physician and Surgeon certificate; DO licenses follow a distinct CMB format but are retrievable through the same CMB BreEZe search module); initial license issue date (the date the CMB first issued the Physician and Surgeon certificate to the individual, following successful completion of the applicable USMLE or COMLEX examination pathway, residency training verification, and background check); current expiration date (CMB licenses must be renewed on a biennial cycle; the CMB sends renewal notices and the licensee must complete continuing medical education requirements as a condition of renewal — a license that expires without timely renewal lapses and the practitioner is no longer authorized to practice medicine in California); and current status: Clear (the CMB licensee holds a valid, current license in good standing with no active disciplinary conditions — fully authorized to practice medicine, surgery, and controlled substance prescribing within their scope of training), Probation (the CMB has entered a disciplinary decision imposing probationary terms on the licensee following a formal accusation proceeding — Probation status may include restrictions on the licensee's practice scope, requirements for a practice monitor, mandatory substance abuse treatment, restricted or prohibited controlled substance prescribing authority, required CMB compliance reporting, and a probationary period specified in the CMB decision; a Probation-status licensee is subject to CMB conditions that, if violated, constitute grounds for suspension or revocation), Suspended (the CMB has entered a disciplinary order suspending the licensee's Physician and Surgeon certificate — a suspended CMB licensee has no authority to practice medicine in California during the suspension period; any medical services, prescriptions, or procedures performed during the suspension period constitute unlicensed practice under § 2052 regardless of the practitioner's educational background or prior licensure history), or Revoked (the CMB has revoked the Physician and Surgeon certificate following a formal accusation proceeding under Bus. & Prof. Code § 2227 — the most severe CMB disciplinary action; a revoked CMB licensee has permanently lost their California physician and surgeon certificate and any medical services performed after revocation constitute unlicensed practice under § 2052; the revoked licensee may petition for reinstatement under Bus. & Prof. Code § 2307, but reinstatement is not automatic and requires CMB approval).

When the attorney searches the CMB BreEZe database and confirms the defendant practitioner's absence from the Clear CMB licensee roster — or confirms that the defendant's CMB license shows Probation, Suspended, or Revoked status during the period the challenged medical services were rendered — the search date establishes the secondary Welch anchor for the CLRA § 1780 fee petition lodestar. The CMB BreEZe search result — a screenshot or printout from the CMB BreEZe online portal showing the defendant's name, license number (if any), license type, and current status — is preserved as a dated exhibit to the fee petition. In cases involving extended periods of unlicensed practice, the attorney searches the CMB BreEZe database with respect to multiple relevant dates — the date each patient was first seen, the date each controlled substance prescription was issued, the date each procedure was performed — confirming that the defendant lacked Clear CMB licensure throughout the relevant period, a temporal verification exercise that establishes the full scope of the unlicensed practice period and supports a lodestar calculation encompassing all attorney time from the first CMB BreEZe search date through judgment. In cases where the defendant holds a Probation-status CMB license, the attorney obtains and reviews the CMB probationary decision and probation conditions to determine whether the specific unlicensed-practice-adjacent conduct (e.g., restricted controlled substance prescribing, required practice monitor) constitutes a violation of probationary terms that escalates the § 2052 civil liability analysis and the Ketchum multiplier briefing.

The CMB BreEZe module is structurally distinct from every other California licensing board database in the fee-petition-mechanics series in several important respects. First, it is the only DCA BreEZe module that covers both MD (allopathic) and DO (osteopathic) physician licenses under a unified single-board module — the CMB has had jurisdiction over both MD and DO licenses in California since the Medical Board of California was reorganized to consolidate both licensing authorities; this unified MD-DO jurisdiction distinguishes the CMB BreEZe from every other DCA board BreEZe module, which covers a single license type under a single practitioner category. Second, the CMB BreEZe covers only individual MD and DO licenses — CMB does not separately license medical corporations, medical groups, or physician practice entities through the BreEZe module; medical corporations organized under Corporations Code § 13401 must be registered with the California Secretary of State and must identify their controlling licensed physician's CMB license number in their corporate filings, but the medical corporation registration is a separate administrative process from the CMB BreEZe individual physician license verification; this individual-only licensing architecture for the CMB BreEZe makes it distinct from the dual individual-and-entity CBA BreEZe module (which covers both individual CPA C-number licenses and CPA firm FRM-number permits to practice under a single dual-module BreEZe interface) and from the multi-discipline BPELSG BreEZe module (which covers multiple engineer, land surveyor, and geologist license categories under a single multi-discipline BreEZe interface). Third, the CMB BreEZe is the highest-volume DCA BreEZe module in terms of active licensee population — approximately 160,000 active MD and DO licensees — reflecting California's status as the most populous U.S. state with the largest physician workforce; this high licensee volume means the CMB BreEZe search by defendant name may return multiple results with similar names, requiring the attorney to cross-reference by license number, license issue date, and the defendant's biographical information to confirm the correct licensee record.

Billing Gap 1 — CMB BreEZe License Verification Database Search, § 2052 Unlicensed Practice Analysis, DEA COR Verification, Medical Records Review, and CURES 2.0 Prescription History Analysis (6.50 hrs/yr = $1,950–$3,250)

The first billing gap arises in the pre-complaint advisory phase — from initial patient contact through Tyler Odyssey complaint filing — during which the attorney searches the CMB BreEZe License Verification Database, verifies the defendant's DEA Certificate of Registration status, reviews medical records and treatment notes to document the specific unlicensed medical services performed, and analyzes the CURES 2.0 controlled substance prescription history to identify controlled substance prescriptions issued under the defendant's name or a fictitious or borrowed DEA COR number, establishing both the § 2052 civil predicate and the § 2052(b) treble damages quantification framework for the Tyler Odyssey complaint.

• Searching CMB BreEZe for defendant's MD/DO license status and cross-referencing DEA COR status via DEA Diversion Control Division online registrant search for controlled substance prescribing authority: the attorney performs the CMB BreEZe License Verification Database search by the defendant practitioner's full legal name — and, where available, by the defendant's self-represented CMB license number from prescriptions, clinic letterhead, online provider profiles, or patient intake documents — verifying whether the defendant's name corresponds to an active CMB licensee with a Clear (or Probation, Suspended, or Revoked) status, and confirming the license number format (A-NNNNN for MD licenses) and the current license expiration date relative to the dates of the challenged medical services; the attorney then performs a DEA Diversion Control Division online registrant search (available at the DEA's online Diversion Control Division practitioner registration lookup) to determine whether the defendant holds a current, active DEA Certificate of Registration (COR) in California for the applicable controlled substance schedules (Schedules II, III, IV, and/or V); a valid DEA COR requires an underlying state medical license in the state of registration — the DEA will not issue or renew a COR to a practitioner who lacks a current CMB MD or DO license in California — so a defendant who lacks a Clear CMB license will also lack a valid California DEA COR; the attorney documents the specific controlled substances prescribed or dispensed by the defendant (by reviewing prescription records, pharmacy dispensing records, and CURES 2.0 print-outs) and cross-references each controlled substance with the schedule classification under California Health and Safety Code § 11055 et seq. and the federal Controlled Substances Act schedules, identifying the specific § 841(a)(1) violation dimension for each controlled substance prescription issued without DEA COR authority.
• Reviewing medical records, treatment notes, prescriptions, and surgical procedure reports to document the specific unlicensed medical services performed and the harm profile: the attorney obtains and reviews all available medical records generated by the defendant's unlicensed practice — patient intake forms, history and physical examination notes, diagnosis records, treatment plans, prescription records, procedure reports, post-procedure notes, follow-up records, and billing records — to document: (a) the specific medical services the defendant performed (diagnosis, treatment, surgical procedure, controlled substance prescription, or combination), identifying each service as physician-level medical practice requiring a CMB MD or DO license under Bus. & Prof. Code § 2052; (b) the patient harm profile arising from each unlicensed service — physical harms from surgical procedures performed without CMB-licensed surgical competency (wound infection, nerve injury, septic joint, anesthesia adverse event), diagnostic harms from misdiagnosis or delayed diagnosis by an unlicensed practitioner lacking physician-level clinical training, prescription harms from controlled substance prescriptions issued without a CMB-licensed physician's patient monitoring protocol and CURES 2.0 prescriber oversight, and financial harms from all fees paid to the unlicensed practitioner for services the defendant lacked authority to render; (c) the downstream medical costs incurred to diagnose and treat complications arising from the unlicensed practice — emergency room visits, hospitalization, specialist consultation, corrective surgical procedures, wound care, rehabilitation, and ongoing treatment for conditions caused or worsened by the unlicensed practice; and (d) the non-economic damages — physical pain, emotional distress, loss of enjoyment of life, and loss of consortium — arising from patient harm that would not have occurred had the defendant's unlicensed status been disclosed before the patient sought care from the defendant.
• Analyzing CURES 2.0 (California Controlled Substance Utilization Review and Evaluation System) prescription history to identify controlled substance prescriptions attributed to the unlicensed defendant and quantify the controlled substance distribution dimension: CURES 2.0, administered by the California Department of Justice, is California's prescription drug monitoring program (PDMP) — a secure online database recording every controlled substance prescription dispensed by a California pharmacy, indexed by the prescriber's DEA COR number and the patient's identifying information; California Health and Safety Code § 11165.1 requires pharmacies and dispensing practitioners to report all Schedule II–IV controlled substance prescriptions to CURES 2.0 within one working day of dispensing; CMB-licensed physicians are required to check CURES 2.0 before prescribing opioids, benzodiazepines, and other Schedule II–IV controlled substances to a patient for the first time or after a 12-month gap in treatment (Health & Safety Code § 11165.4); an unlicensed practitioner who issued controlled substance prescriptions will have CURES 2.0 records showing prescriptions attributed to a DEA COR number — either a COR number belonging to a different (licensed) practitioner whose DEA registration was fraudulently borrowed or stolen, a fictitious DEA COR number fabricated by the defendant, or a COR number associated with the defendant's name that was obtained through misrepresentation of CMB licensure status; the attorney obtains CURES 2.0 print-outs through patient authorization and, where available, through discovery in the civil action, to document the full controlled substance prescription history, identify all Schedule II–V controlled substances prescribed by the defendant, quantify the volume of unlicensed controlled substance distribution, and corroborate the § 841(a)(1) federal criminal exposure dimension of the defendant's conduct — a dimension that, while creating no private civil right of action, informs the § 2052(b) treble damages quantification and the Ketchum multiplier briefing on the severity and public harm of the unlicensed practice.

Billing Gap 2 — Active Litigation Phase: Discovery from Defendant and Unlicensed Practice Entity, Surgical Expert Consultation, § 2052(b) Treble Damages Quantification, and CLRA § 1780 Fee Petition with Ketchum Multiplier and PLCM Group Market Rate Affidavit (4.00 hrs/yr = $1,200–$2,000)

The second billing gap arises from the active litigation and CLRA § 1780 mandatory attorney fee petition phase — from Tyler Odyssey complaint through trial or settlement and the post-judgment fee petition — during which the attorney conducts discovery from the defendant practitioner and any clinic or medical office entity through which the unlicensed services were rendered, consults with a CMB-licensed medical expert on standard of care violations and patient harm causation, quantifies actual damages for § 2052(b) treble damages briefing, and prepares the complete CLRA § 1780 fee petition lodestar with Ketchum multiplier briefing and PLCM Group market rate affidavit.

• Conducting discovery from defendant (practice records, patient lists, procedure logs, prescription pads, DEA COR documentation or absence thereof, entity formation documents) and any clinic or "medical office" through which unlicensed services were rendered: the attorney conducts discovery targeting the defendant practitioner and any clinic, wellness center, medical spa, or "medical office" entity through which the unlicensed services were rendered; discovery from the defendant practitioner includes: the defendant's complete patient list and treatment records for the relevant period (establishing the scope of the unlicensed practice and identifying all affected patients, which may support UCL § 17200 class-wide restitution and a CCP § 1021.5 private attorney general fee enhancement); the defendant's prescription records and prescription pads (identifying all controlled substance prescriptions issued under the defendant's name, the DEA COR number used on each prescription, and the specific controlled substances prescribed — documenting the full § 841(a)(1) dimension); the defendant's procedure logs for all surgical and invasive procedures performed (establishing the specific procedures performed, the dates and clinical settings, and any post-procedure records); documentation of any DEA COR held by the defendant or used by the defendant (whether the COR was issued to the defendant, borrowed from another practitioner, or fabricated); entity formation documents for any clinic or practice entity through which the defendant operated (identifying the corporate or organizational structure, the names of any other principals, and any licensing representations made by the entity to patients or insurers); and billing records and insurance claim submissions (which may show the defendant billing under a different CMB-licensed physician's provider number — a separate fraud dimension supporting punitive damages in addition to § 2052(b) treble damages); discovery from any clinic or "medical office" entity includes: the entity's business formation documents and any professional corporation registration under Corporations Code § 13401; the entity's credentialing file for the defendant practitioner (if any); any insurance contracts or payor agreements the entity entered as a medical provider; and the entity's own representations to patients about the defendant's credentials (online listings, patient intake forms, clinic signage, marketing materials).
• Consulting with a medical expert (CMB-licensed MD or DO) to opine on standard of care violations, medical necessity analysis, and causal connection between unlicensed procedures and patient harm — supporting both actual damages and § 2052(b) treble damages quantification: the attorney retains a CMB-licensed MD or DO expert in the relevant clinical specialty to review the defendant's medical records, procedure reports, and prescription records and opine on: (a) the standard of care applicable to the specific medical services the defendant performed — what a CMB-licensed physician in the defendant's represented specialty would have done in the same clinical situation; (b) the deviations from the applicable standard of care attributable to the defendant's lack of CMB licensure and the associated lack of physician-level clinical training, residency experience, and CMB-mandated continuing medical education; (c) the causal connection between the defendant's specific unlicensed practice violations (the inadequate surgical technique, the unmonitored controlled substance prescribing, the missed diagnosis, or the contraindicated treatment) and the specific patient harms documented in the medical records; (d) the medical necessity and reasonableness of the downstream medical treatment costs incurred to treat complications arising from the unlicensed practice — supporting the actual damages quantification for § 2052(b) treble damages purposes; and (e) the non-economic damages — physical pain, emotional distress, and loss of function — arising from patient harms that would not have occurred had the defendant disclosed the unlicensed status and the patient sought care from a CMB-licensed physician; the medical expert's opinion provides the causation foundation for both the negligence count and the § 2052(b) treble damages count in the Tyler Odyssey complaint, and the expert's opinions on the severity and irreversibility of patient harm support the Ketchum multiplier briefing on the exceptional complexity and public importance of the § 2052 / CLRA § 1780 representation.
• Documenting the CLRA § 1780 fee petition lodestar (CMB BreEZe search through Tyler Odyssey complaint through judgment) with Ketchum v. Moses multiplier briefing on the PURE KETCHUM status, the surgical harm complexity premium, and PLCM Group Inc. v. Drexler (22 Cal.4th 1084 (2000)) market rate affidavit; Missouri v. Jenkins fees-on-fees for all fee petition preparation time: the CLRA § 1780 fee petition documents the complete lodestar beginning with the CMB BreEZe License Verification Database search session — establishing the secondary Welch anchor date — and proceeding through the full Tyler Odyssey complaint through judgment timeline; the fee petition narrative applies the Hensley v. Eckerhart (461 U.S. 424 (1983)) lodestar reasonableness framework, documenting the relationship between each pre-complaint advisory task (CMB BreEZe search, DEA COR verification, CURES 2.0 analysis, medical records review), each active litigation task (discovery from defendant and clinic entity, medical expert consultation, § 2052(b) treble damages quantification), and the overall successful result in the CLRA § 1780 and § 2052(b) claims; the Ketchum multiplier analysis emphasizes: (a) the PURE KETCHUM status — the entire CLRA § 1780 lodestar is eligible for the full contingency multiplier without any Dague constraint, because no federal statute creates a mandatory civil fee-shifting mechanism for unlicensed California medical practice claims, eliminating any need for lodestar segregation between Ketchum-eligible and Dague-constrained portions; (b) the surgical harm complexity premium — cases involving patients who underwent unlicensed surgical procedures require medical expert coordination, causation analysis, and § 2052(b) treble damages briefing that demands expertise in California medical malpractice law, California discovery law, and the intersection of § 2052(b) treble damages and CLRA § 1780 mandatory fees that is not routinely demanded in standard consumer protection cases; (c) the controlled substance prescribing complexity premium — DEA COR verification, CURES 2.0 analysis, and § 841(a)(1) federal criminal dimension documentation requires knowledge of the federal Controlled Substances Act, the California CURES 2.0 system, and the interface between state civil liability and federal criminal exposure; the PLCM Group market rate analysis documents the prevailing hourly rate in the California legal community for a solo practitioner handling CLRA § 1780 / § 2052(b) unlicensed medical practice matters; Missouri v. Jenkins (491 U.S. 274 (1989)) fees-on-fees recovery encompasses all time preparing the CLRA § 1780 fee petition — the CMB BreEZe search narrative, the secondary anchor establishment chronology, the PURE KETCHUM analysis, the Ketchum multiplier briefing, the PLCM Group market rate affidavit, and all reply briefing responding to the defendant's fee petition opposition.

Billing Gap 3 — Bus. & Prof. Code § 2052(b) Treble Damages Lodestar Briefing: Quantifying Actual Damages Trebled, § 2052(b) Civil Cause of Action Pleading, and CMB Enforcement Action Coordination (4.00 hrs/yr = $1,200–$2,000)

The third billing gap arises from the § 2052(b) treble damages briefing and CMB enforcement coordination phase — a distinct set of legal tasks that are specific to Bus. & Prof. Code § 2052 unlicensed medical practice cases and that do not arise in any other page in the fee-petition-mechanics series — during which the attorney quantifies actual damages for statutory trebling under § 2052(b), coordinates with the CMB Complaint Unit on the CMB's independent investigation of the defendant's unlicensed practice, and briefs the § 2052(b) treble damages count as a distinct lodestar component from the CLRA § 1780 mandatory fee base, with Missouri v. Jenkins fees-on-fees for all § 2052(b) treble damages briefing preparation time.

• Quantifying actual damages for trebling under § 2052(b): all amounts paid to the unlicensed practitioner for medical services, all downstream medical costs caused by the unlicensed practice, and all non-economic damages supported by the patient's medical evidence: the § 2052(b) treble damages quantification requires comprehensive actual damages documentation in three categories; first, direct fees paid to the unlicensed practitioner — all office visit fees, consultation fees, procedure fees, laboratory fees billed by the defendant's "clinic" or "practice," prescription dispensing fees for any controlled substances dispensed directly by the defendant, and any facility fees charged by the clinic entity through which the unlicensed services were rendered; second, downstream medical costs caused by the unlicensed practice — emergency room visits and hospitalization required to treat complications of unlicensed procedures (surgical wound infection, septic joint, anesthesia adverse event, overdose or toxicity from unmonitored controlled substance prescribing); specialist consultation with CMB-licensed physicians required to assess, manage, and treat complications; corrective surgical procedures performed by CMB-licensed surgeons to repair harms caused by the defendant's unlicensed surgical technique; rehabilitation and physical therapy for patients who suffered nerve injury, joint damage, or musculoskeletal harm from unlicensed procedures; ongoing medication costs for treating conditions caused or worsened by the unlicensed practice; and any other downstream medical costs arising from the patient's need to obtain physician-level care from a CMB-licensed practitioner to address harms the defendant caused; third, non-economic damages — physical pain, suffering, and emotional distress arising from the patient harm, including the distress of learning that the practitioner who provided medical services, performed surgical procedures, or prescribed controlled substances was unlicensed; the attorney documents each category of actual damages with supporting records (medical bills, insurance explanation-of-benefits statements, pharmacy receipts, rehabilitation invoices) and applies the § 2052(b) statutory treble damages multiplier to the total actual damages figure to arrive at the § 2052(b) treble damages demand, which is then incorporated into the CLRA § 1780 fee petition lodestar as a distinct damages component supporting the overall recovery briefing.
• Coordinating with CMB enforcement staff (CMB Complaint Unit, via formal complaint filing) to document the CMB's independent investigation of the defendant's unlicensed practice: the attorney files a formal complaint with the CMB Complaint Unit (the CMB's consumer complaint intake office, reached through the DCA's BreEZe online complaint system or by mail to the CMB's Sacramento enforcement office) describing the defendant's unlicensed practice, the specific medical services rendered without CMB licensure, the controlled substance prescriptions issued without a valid DEA COR, and the patient harms resulting from the unlicensed practice; the CMB Complaint Unit assigns the complaint to a CMB investigator, who may open a formal CMB investigation of the defendant's unlicensed practice under Bus. & Prof. Code § 2220; the CMB investigation may result in a CMB Accusation filed against the defendant under Bus. & Prof. Code § 2227 — an Accusation is a formal administrative charging document alleging specific violations of the Medical Practice Act; if a CMB Accusation is filed, its allegations of unlicensed practice or license status violations directly corroborate the § 2052 civil predicate, and the Accusation's factual allegations may be admissible in the civil action as party admissions (if the defendant is the same individual named in the Accusation) or as public records under Evidence Code § 1280; in cases where the CMB has already taken disciplinary action against the defendant before the civil action is filed — resulting in a publicly-available CMB disciplinary decision reflected in the CMB BreEZe record as Probation, Suspended, or Revoked status — the CMB disciplinary decision is itself a powerful exhibit to the CLRA § 1780 fee petition, establishing the § 2052 predicate violation through the CMB's own adjudicative findings; the attorney also monitors the CMB investigation timeline for coordination with the civil discovery schedule, ensuring that CMB investigation records (which may be subject to California Government Code § 6250 et seq. Public Records Act disclosure after the investigation concludes) are obtained through civil discovery or PRA request to supplement the civil record.
• Briefing § 2052(b) treble damages as a distinct lodestar component from the CLRA § 1780 mandatory fee base: the § 2052(b) civil action provides for actual damages trebled as a separate civil cause of action from the CLRA § 1780 consumer protection claim, and the fee petition documents the separate legal work performed on the § 2052(b) treble damages count with Missouri v. Jenkins fees-on-fees for the § 2052(b) treble damages briefing preparation time: the CLRA § 1780 fee petition in a § 2052 / § 2052(b) unlicensed medical practice case has a layered lodestar structure that is unique among all pages in the fee-petition-mechanics series; the CLRA § 1780 mandatory fee base covers all attorney time reasonably expended on the CLRA § 1770(a)(14) credential misrepresentation claim and the UCL § 17200 per se unlawful business practice claim, from the CMB BreEZe secondary anchor search through judgment; the § 2052(b) treble damages component covers all attorney time reasonably expended on the distinct § 2052(b) civil cause of action — including the actual damages quantification analysis (documenting direct fees paid, downstream medical costs, and non-economic damages), the medical expert consultation supporting the causation analysis for the § 2052(b) actual damages, the § 2052(b) treble damages briefing in the operative complaint and any demurrer opposition, the § 2052(b) treble damages jury instruction preparation (where the case is tried to a jury), and the § 2052(b) treble damages section of the post-trial judgment or settlement demand; the fee petition documents this layered structure explicitly — identifying the specific billing entries attributable to the CLRA § 1780 claim, the entries attributable to the § 2052(b) treble damages claim, and entries attributable to both claims (such as the CMB BreEZe search, which establishes the predicate for both § 2052 and CLRA § 1770(a)(14)); Missouri v. Jenkins (491 U.S. 274 (1989)) fees-on-fees recovery is sought for all time preparing the fee petition itself — including the actual damages trebling analysis, the § 2052(b) lodestar component briefing, the PURE KETCHUM analysis, the Ketchum v. Moses multiplier briefing, and all reply briefing on the fee petition; the fee petition narrative emphasizes that the § 2052(b) treble damages briefing work would not have been necessary absent the defendant's § 2052 unlicensed practice, directly causally connecting the § 2052(b) lodestar component to the underlying unlicensed practice predicate and establishing Missouri v. Jenkins fees-on-fees entitlement for all fee petition preparation time.

Total Annual Billing Gap — Three-Gap Summary

• Gap 1 (CMB BreEZe search, § 2052 analysis, DEA COR verification, CURES 2.0 prescription history): 6.50 hrs = $1,950–$3,250/yr
• Gap 2 (active litigation, discovery, surgical expert consultation, § 2052(b) treble damages quantification, CLRA § 1780 fee petition): 4.00 hrs = $1,200–$2,000/yr
• Gap 3 (§ 2052(b) treble damages lodestar briefing, CMB enforcement action coordination, fee petition preparation): 4.00 hrs = $1,200–$2,000/yr
• Total: 14.50 hrs = $4,350–$7,250/yr untracked at $300–$500/hr median California solo practitioner rate

Related California Attorney Fee Petition Pages

• California Physician Assistant Board — Bus. & Prof. Code § 3526
• California Board of Registered Nursing — Bus. & Prof. Code § 2878
• California Dental Practice Act — Bus. & Prof. Code § 1680